Advanced Enzymes acquires evoxx

02-Aug-2017 - Germany

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a binding agreement about the acquisition of 100% stake in evoxx technologies.

evoxx technologies is proud to announce that it will become part of the global enzyme manufacturing company Advanced Enzyme Technologies Limited. evoxx and its team of 35+ scientists & technicians across the two sites in Germany, Monheim am Rhein and Potsdam, will be the Research & Development centers and sales points of Advanced Enzymes in Europe. V.L. Rathi, Chairman, Advanced Enzymes, said,

“evoxx has a great strategic fit for us. With evoxx we significantly expand our R&D capabilities and also strengthen our European presence.”

The acquisition will give Advanced Enzymes a stronger foothold in Germany and in Europe and will also help strengthen its Research & Development capabilities. The acquisition will also help Advanced Enzymes expand its enzyme portfolio & business in biocatalysis and food applications.

“Together with the strong partners in India and USA, the portfolio of industrial enzymes will be larger and more attractive for the existing and future customers of evoxx. Furthermore, the production plants and production knowledge of Advanced Enzymes will help evoxx deliver enzymes in industrial scale,” said Dr. Thorsten Eggert, CEO of evoxx technologies.

Notwithstanding the acquisition, evoxx will ensure continuity in cooperative projects with customers and partners. The proprietary technology platform of evoxx technologies to develop tailor-made enzymes and processes for various industries will be still available in the future.

https://www.bionity.com/en/news/164348/advanced-enzymes-acquires-evoxx.html